Gregory D Perry is of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 10,894 shares of KALA, which is worth approximately $67,324. The most recent transaction as insider was on Jun 11, 2024, when has been sold 1,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.9K
0% 3M change
14.75% 12M change
Total Value Held $67,324

GREGORY D PERRY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
1,400 Added 11.39%
10,894 Common Stock
Jun 22 2023
BUY
Grant, award, or other acquisition
-
6,956 Added 42.29%
9,494 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
1,738 Added 40.65%
2,538 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 33.33%
40,000 Common Stock

Also insider at

FNCH
Finch Therapeutics Group, Inc. Healthcare
MRUS
Merus N.V. Healthcare
GDP

Gregory D Perry

Utretcht, P7

Track Institutional and Insider Activities on KALA

Follow Kala Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALA shares.

Notify only if

Insider Trading

Get notified when an Kala Pharmaceuticals, Inc. insider buys or sells KALA shares.

Notify only if

News

Receive news related to Kala Pharmaceuticals, Inc.

Track Activities on KALA